Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, new research presented at the European Association for the Study of Diabetes (EASD) has suggested.

A recent study from Oregon Health & Science University (OHSU) has highlighted the connection between misaligned circadian rhythms and increased metabolic risk factors in individuals living with overweight or obesity.

Intermittent fasting is just as effective as traditional calorie restriction for weight loss in teenagers with obesity, according to a new Australian study.

The growing child obesity crisis in England has been highlighted by an interactive map showing areas where nearly half of children are living with overweight or obesity by the time they enter secondary school.

A recent study sheds light on the possible connection between obesity and a higher risk of multiple sclerosis (MS) in women, suggesting that inflammation specific to females may play a crucial role in this increased susceptibility.

Gaining even a small amount of weight could significantly impact the metabolic health of young South Asian men, according to a recent study led by the University of Glasgow and published in Nature Metabolism.

Academics at the University of Liverpool have found that the weight loss drug, Tirzepatide is associated with a significantly reduced risk of developing type 2 diabetes.

A recent study at ETH Zurich sheds light on why the choice between exercise and indulging in a treat isn't just a matter of willpower. The study reveals that a brain chemical called orexin plays a crucial role in tipping the balance between physical activity and indulgence.

A recent clinical trial has shown that an older obesity drug from Novo Nordisk, known for its weight loss benefits, may have a positive effect on brain health in patients with mild Alzheimer's disease. The trial, which involved just 204 patients in Britain, provides an early indication of how GLP-1 receptor agonist drugs might work on challenging brain disorders.

A recent study published in The Lancet Public Health has revealed a significant link between higher BMI in early adulthood and an increased risk of cardiovascular diseases in a Chinese population.

A widening disparity in childhood obesity rates in Southampton is set to worsen, a public health chief has warned.

New research suggests a NHS diet programme can help people reverse type 2 diabetes by adhering to a strict 900-calorie-a-day liquid diet.

Recent research published in The Lancet has shed new light on the mechanisms behind the effectiveness of bariatric surgery for obesity treatment, revealing significant changes in bile acid metabolism that may contribute to sustained weight loss and enhanced glucose metabolism.

A recent study has added further support to the idea that semaglutide, the active ingredient in popular medications such as Ozempic and Wegovy, could play a significant role in treating addiction.

New research points to a promising natural alternative to Semaglutide - beta-glucan.

A new study published in The Lancet Regional Health—Europe has found significant declines in mortality rates among those living with obesity in England from 2004 to 2019.

New study finds Semaglutide can significantly help people with HIV combat fatty liver disease. This revelation offers new hope for improving the quality of life and longevity for HIV patients.

A recent study published in JAMA Network Open has revealed that certain diabetes treatments might lower the risk of obesity-related cancers.

Weight-loss treatment Wegovy has recently been approved by the UK's medicines regulator to reduce the risk of serious heart problems in overweight and obese people.